Skip to main content
. 2019 Apr 12;40(4):398–405. doi: 10.1093/jbcr/irz063

Table 2.

Number of patients with elbow heterotopic ossification (HO) described by oxandrolone administration and HO risk score

No Oxandrolone Oxandrolone
HO Risk Score No HO HO Total No HO HO Total
7 17 4 21 3 0 3
8 11 1 12 5 0 5
9 10 3 13 9 0 9
10 12 1 13 5 6 11
11 5 3 8 0 2 2
12 2 1 3 0 2 2
13 1 1 2 0 0 0
Total 58 14 72 22 10 32